Arch Venture Partners Xiv, L.P.
At a glance: Arch Venture Partners Xiv, L.P. is 10% Owner at Aspen Neuroscience (ASPE). Their latest SEC Form 4, filed Nov 2, 2026, reported a purchase of $18.0M. On file: 1 purchase line ($18.0M) and 0 sale lines ($0).
10% Owner at Aspen Neuroscience, Inc. (ASPE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3.4M
Total bought / sold$18.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 2SEC | ASPEAspen Neuroscience, Inc. | Buy | 1,200,000new position | $15.00 | $18.0M | -18.7% |
- Buy
10% Owner Arch Venture Partners Xiv, L.P. bought $18.0M of ASPE at $15.00 — first open-market purchase in our records; opens a new position.